Applied Opto corrects Q1 2024 non-GAAP net loss outlook to $10.9M-$12.6M; reports Q4 non-GAAP net income $1.6M

APPLIED OPTOELECTRONICS, INC.

2023-FY EPS reported -$1.75 revenue$217,646,000

Corrected Q1 2024 non-GAAP net loss range from $18.9M-$20.8M to $10.9M-$12.6M due to clerical error.
Q4 2023 revenue $60.5M; GAAP gross margin 35.7% (up from 10.1% YoY); non-GAAP net income $1.6M ($0.04 diluted EPS).
Full year 2023 revenue $217.6M (down 2% YoY); GAAP net loss $56.0M ($1.75 per share); non-GAAP net loss $13.3M ($0.42 per share).
Management guided Q1 2024 revenue decline due to Lunar New Year and price reductions; expects substantial improvement in Q2.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

APPLIED OPTOELECTRONICS, INC. reported the fourth quarter and full year ended December 31, 2023 results: revenue $60.5 million, net income GAAP net loss was $13.9 million, or $0.38 per basic share, EPS $0.38 per basic share.

Period: the fourth quarter and full year ended December 31, 2023
Revenue: $60.5 million
Net income: GAAP net loss was $13.9 million, or $0.38 per basic share
EPS: $0.38 per basic share
Result: reported results

Exact text from the filing

in Q1 due to the Lunar New Year combined with some price reductions, with substantial improvement expected in Q2.” Fourth Quarter 2023 Financial Summary · GAAP revenue was $60.5 million, compared $61.6 million in the fourth quarter of 2022 and $62.5 million in the third quarter of 2023. · GAAP gross margin was 35.7%, compared with 10.1% in the fourth quarter

View on SEC.gov

Browse all earnings releases →

APPLIED OPTOELECTRONICS, INC. filing history →

Source: SEC EDGAR

accession 0001683168-24-001140

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.